RSV
Clinical trials for RSV explained in plain language.
Never miss a new study
Get alerted when new RSV trials appear
Sign up with your email to follow new studies for RSV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new RSV vaccine keep adults out of the hospital? 690,000 join trial
⭐️ VACCINE ⭐️ OngoingThis massive study is testing whether the Abrysvo RSV vaccine can prevent hospitalizations due to RSV in adults aged 18 and older. Half of the 690,000 participants will receive the vaccine, while the other half will not. Researchers will track how many in each group end up hospit…
Matched conditions: RSV
Phase: PHASE4 • Sponsor: Tor Biering-Sørensen • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:00 UTC
-
Can a new model help botswana shield infants from RSV?
Knowledge-focused OngoingThis study aims to create a health economic model that estimates the costs and health benefits of different RSV prevention strategies for infants in Botswana. Researchers will gather input from policymakers, healthcare providers, funders, and other stakeholders through interviews…
Matched conditions: RSV
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Could vitamin d levels predict wheezing after bronchiolitis?
Knowledge-focused OngoingThis study investigates whether vitamin D levels, genetic variations in the vitamin D receptor, and changes in immune cell mitochondria can help predict which children will develop recurrent wheezing after a bout of bronchiolitis. Researchers will measure these markers in childre…
Matched conditions: RSV
Sponsor: National and Kapodistrian University of Athens • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC